Background/Aims: Basophils have been reported to infiltrate skin lesions in various skin diseases, but not in systemic lupus erythematosus (SLE). This study investigated basophil infiltration in SLE and its mechanism. Methods: Twenty newly diagnosed SLE patients and twenty healthy controls were enrolled. Nine SLE patients underwent skin biopsies. Flow cytometric analysis the phenotype of peripheral basophils and their migration rate toward RANTES and MCP-1 were analyzed with the transwell culture system, also the expression of these two chemokines in skin tissue were analyzed with immunohistochemistry. Results: Increased activation and decreased numbers of peripheral basophils were observed in SLE patients compared with controls. Basophil migration into skin lesions of SLE patients were observed, but not in normal skin tissue. This migration was related to the upregulation of chemokine receptors CCR1 and CCR2 on basophils. In vitro studies showed that migration rate toward RANTES and MCP-1 increased significantly in basophils from SLE patients compared with those from controls. Consistently, high levels of RANTES and MCP-1 expression were observed in skin lesions from SLE patients but not in normal skin tissue. Conclusion: Basophil recruitment to skin lesions of SLE patients mediated by CCR1 and CCR2, which may contribute to tissue damage in SLE.
. Demographic characteristics of SLE patients and healthy controls Table 1 . Demographic characteristics of SLE patients and healthy controls.
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Introduction
Basophils are the least abundant granulocyte, representing 1% of circulating leukocytes. However, recent studies have highlighted its emerging role in health and disease [1] . Our increasing understanding of the function of basophils in immunology is based on newly developed functional analysis tools, including basophil-depleting antibodies (e.g., monoclonal antibodies specific for the high-affinity IgE receptor [FcεRI] and CD200 Receptor-like 3 [CD200R3]) and genetically engineered mice that are only deficient in basophils [2] [3] [4] . These advances have fueled basophil research and defined previously unrecognized basophil functions.
Basophils have been reported to infiltrate into skin lesions in various inflammatory and allergic skin diseases, such as atopic dermatitis, urticaria, bullous pemphigoid, drug eruptions, insect bites, scabies, and dermatomyositis [5] . Chemokines and their receptors help regulate this inflammatory site infiltration. Human basophils express the chemokine receptors (CCR)1, CCR2, CCR3, and CCR5 to mediate their infiltration into inflammatory sites [6, 7] . However, further investigations are needed to determine which chemokine receptors are involved in mediating basophil infiltration of skin lesions and what specific circumstances elicit this infiltration.
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease involving multiple organs, including skin, brain, lungs, and kidneys [8, 9] . Skin lesions are a common presentation in patients with SLE. As many as 70% of people with lupus have some skin symptoms, and approximately 25% of patients have cutaneous manifestations as a presenting sign [10, 11] . Skin involvement is second only to joint manifestations as the predominant manifestation of SLE, both at onset and later stages of the disease [12, 13] . Cutaneous manifestations are correlated with disease activity in SLE, which gives them diagnostic value [14] . As was known, several types of immune cells [15] [16] [17] , including basophils [18] have been reported to exacerbate SLE by amplifying production of autoantibodies and inflammatory cytokines. However, we do not know if basophils infiltrate skin lesions in SLE, and if they do, what are the mechanisms of this infiltration.
This study aimed to investigate basophil infiltration into SLE skin lesions and the infiltration mechanism, both in patients with SLE and in vitro, which should provide novel insights into the pathogenesis of skin lesions in SLE.
Materials and Methods

Patients
Twenty newly diagnosed treatment-naïve patients with SLE (SLE patients) met the diagnostic criteria for SLE, as outlined by the American College of Rheumatology (Table 1 ) [19] . SLE patients were enrolled in this study from August 2014 to August 2015 at the Department of Nephrology, the Affiliated Hospital of Guangdong Medical University. Twenty healthy control subjects (Table 1 ) with no age, sex, or race differences were also enrolled. All subjects provided peripheral blood samples. Nine of the SLE patients with cutaneous lesions underwent skin biopsies to detect tissue basophils ( Table 2 ). Normal skin tissue from cases of trauma or surgery were used as compared controls. The disease activity of the SLE patients was evaluated using the SLE disease activity index [20] . All participants provided written informed consent. The Ethics Committee of the Affiliated Hospital of Guangdong Medical University approved this study. 
Flow cytometric analysis
Human peripheral basophils were gated on CD203c-PE and CD123-PE-Cy7 (Biolegend, San Diego, CA, USA) double-positive cells after extracellular staining. Followed, the expression levels of CD203c-PE, CCR1-Alexflux-647, CCR2-Percp-Cy5.5, CCR3-APC/Cy7 and CCR5-Alexflux-488 (Biolegend, San Diego, CA, USA) in peripheral basophils were quantified and expressed as relative fluorescence units, which is defined as the mean fluorescence intensity normalized to controls.
A FACScanto TM II flow cytometer (Becton Dickinson, San Jose, CA, USA) and the Lysys II software (Becton Dickinson, San Jose, CA, USA) were used to acquire and analyze the data, respectively.
Tissue analysis
Basophils were detected in biopsied skin specimens using the basophil-specific antibody 2D7 (Biolegend, San Diego, CA, USA) [21, 22] . Expression of Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) and monocyte chemotactic protein 1 (MCP-1) was determined using immunohistochemistry with anti-MCP1 and anti-RANTES antibodies (Abcam, Cambridge, MA, USA).
Migration assays
A transwell system (Biolegend, San Diego, CA, USA) was using to detect basophil migration toward RANTES and MCP-1. Briefly, peripheral blood mononuclear cells were isolated from SLE patients and healthy controls using a density gradient procedure (Ficoll-Paque PLUS, GE Healthcare Life Sciences) and resuspended at a cell density of 5×10 6 cells/ml in Dulbecco's Modified Eagle Medium (DMEM) (SigmaAldrich, St. Louis, Missouri, USA) containing 10% FBS (Gibco-Brl, Grand Island, NY, USA). Cell suspensions (100 µl) were pipetted into the upper wells. RANTES (100 ng/ml) or MCP-1 (100 ng/ml) in 600 µl of DMEM were added to the lower chambers. DMEM alone served as the spontaneous-migration control, and cells pipetted into the lower well served as a positive control. Cells were incubated for 2 h at 37°C under 5% CO 2 . Following the incubation period, migrated cells were harvested and stained for flow cytometric analysis as described in Materials and Methods 2.2. RANTES-and MCP-1-induced basophil migration levels were calculated by subtracting the percentage of spontaneously migrating basophils.
Statistical Analysis
All statistical analyses were performed using SPSS 16.0. Two-group comparisons were performed using an independent one-sample t-test. A P-value of <0.05 was considered statistically significant.
Results
SLE patients had increased activity and decreased numbers of peripheral basophils
The representative data of FACS for basophil frequency, CD203c expression were shown (Fig. 1a) . Compared with healthy controls, the basophils in peripheral blood of SLE patients were activated and had increased expression of the activation marker CD203c (Fig.  1b) . However, the number (Fig. 1c) and percentage (Fig. 1d) 
patients were significantly decreased compared with those of healthy controls. These results indicate that peripheral basophil activation could play a role in SLE.
Basophils infiltrate skin lesions of SLE patients
To further explore the decreased numbers of peripheral basophils in SLE patients, we examined the recruitment of basophils to skin lesions in SLE patients [5] . In eight of nine SLE patients with cutaneous lesions receiving skin biopsy, basophils were located in the superficial dermis and perivascular regions of inflammatory sites (Fig. 2b and c) . Basophils were not present in normal skin tissue (Fig. 2a) .
Basophils from SLE patients have higher expression of CCR1 and CCR2
Chemokines and their receptors are involved in the regulation of infiltration into cellular inflammatory sites. Human basophils are known to mediate infiltration by expressing the chemokine receptors CCR1, CCR2, CCR3, and CCR5 [6, 7] . Therefore, we investigated the mechanisms mediating basophil infiltration in skin lesions of SLE patients by evaluating the levels of these CCRs in peripheral basophils. Expression of CCR1 and CCR2 on basophils was significantly higher in SLE patients than healthy controls (Fig. 3) . There was no difference in the expression of CCR3 and CCR5 between SLE patients and healthy controls (data not shown). These findings indicate that CCR1 and CCR2 mediate basophil recruitment to skin lesions in SLE patients. (Fig. 1a) . Peripheral basophils in SLE patients (black bar, n=20) and healthy controls (white bar, n=20) were detected using flow cytometry and activation was determined based on CD203c expression (a). 
Basophils of SLE patients have a higher migration rate toward RANTES and MCP-1
RANTES and MCP-1 are the ligands for CCR1 and CCR2, respectively. Thus, the migratory capacities of basophils toward RANTES and MCP-1 were analyzed [23] . Peripheral basophils from SLE patients had a higher migration rate than those from healthy controls (Fig. 4) .
Skin lesions from SLE patients had higher expression of RANTES and MCP-1
The observation that basophils of SLE patients have a higher migration rate toward RANTES and MCP-1 in vitro prompted us to investigate whether these skin lesions express RANTES and MCP-1. Consistent with the previous results, high MCP-1 and RANTES expression levels were observed in skin lesions from SLE patients but not those from healthy controls (Fig. 5) .
Discussion
Basophils play nonredundant roles in acquired immunity regulation, protective immunity to pathogens, and immunological disorders through the release of cytokines and lipid mediators. They also function as antigen-presenting cells [24] [25] [26] . However, their function in autoimmunity remains poorly understood [18, 27] . The role of basophils in mice has been investigated extensively, both in vivo and in vitro [28] [29] [30] [31] , but not in humans. Thus, there is limited first-hand evidence of what human basophils actually do in in vivo immune responses [32] . In this study, we used human basophils and clinical data to demonstrate that CCR1 and CCR2 mediate basophil recruitment in skin lesions of SLE patients. Basophils need to be activated to fulfill their biological functions [33, 34] . Here, we showed that peripheral basophils were activated and the number of peripheral basophils decreased in SLE patients. We observed basophil infiltration into skin lesions obtained from SLE patients. This process potentially could be mediated by increased expression of the chemokine receptors CCR1 and CCR2 on the surface of basophils. Further, transwell migration assays of peripheral basophils from SLE patients showed increased migration toward the chemokine ligands RANTES and MCP-1 compared with basophils from healthy subjects. Consistent with this observation, we detected high expression of RANTES and MCP-1 in tissue from skin lesions of SLE patients. Another aspect, migration to lymph nodes mediated by CD62L also contributing to the decrease of peripheral basophils in patients with SLE [18] .
Infiltration of basophils in the skin of inflammatory skin diseases has been addressed previously [5] . In this study, eight of nine SLE patients with biopsied skin lesions had basophils in the superficial dermis and perivascular regions of inflammation sites, but no basophils were detected in healthy controls. A previous study by Ito et al. did not find basophils in the skin lesions of the three SLE patients they biopsied [5] . This observation may be due to small sample sizes or because they detected basophils using a different basophil-specific antibody. However, in our study, there was one SLE patient without basophils in their skin lesions. Future studies will need larger samples and more participants to determine why infiltration differs and why some few lesions lack basophils in SLE patients. Furthermore, there are classes of molecules that are involved in the function of immune cells [35] [36] [37] , and the regulation of leukocyte migration and activation by chemokines could contribute to the induction of acute and chronic inflammatory reactions. The CCR ligands RANTES and MCP-1 have been shown to play an important role in lung leukocyte infiltration and the recruitment of eosinophils in asthma pathogenesis [23] . Moreover, injection of RANTES and MCP-1 in rat skin causes mast cell, eosinophil, and macrophage recruitment [23] . Our results showed that the migration rate of basophils toward RANTES and MCP-1 increased in SLE patients, which was consistent with the higher expression of MCP-1 and RANTES at skin lesions of SLE patients.
In summary, this study demonstrates that CCR1 and CCR2 could mediate basophil migration and recruitment to skin lesions of SLE patients, which could contribute to tissue damage in SLE. These findings provide novel insights into the pathogenesis of skin lesions in SLE patients and could lead to the development of new therapeutic strategies for treating SLE.
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